Stockscreener 앱 받기
96.09
0.35%
-0.34
시간 외 거래:
95.00
-1.09
-1.13%
전일 마감가:
$96.43
열려 있는:
$95.81
하루 거래량:
5.81M
Relative Volume:
0.60
시가총액:
$142.45B
수익:
$19.35B
순이익/손실:
$2.78B
주가수익비율:
51.40
EPS:
1.8696
순현금흐름:
$3.82B
1주 성능:
+3.38%
1개월 성능:
-0.82%
6개월 성능:
-6.13%
1년 성능:
+6.93%
1일 변동 폭
$95.69
$96.25
1주일 범위
$93.58
$97.27
52주 변동 폭
$85.98
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
96.09 | 142.95B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
124.54 | 217.71B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
354.82 | 136.34B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.47 | 125.27B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.23 | 50.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific head of cardiac rhythm management, diagnostics to retire, successor named - MassDevice
Westwind Capital Takes $13.80 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Should You Hold On To BSX Stock Despite Its Premium Valuation? - Finviz
Is Boston Scientific Corp. (BSX) Positioned for Solid, Durable Growth? - Insider Monkey
Is Boston Scientific (BSX) One of the Best Healthcare AI Stocks to Buy Now? - Finviz
UBS Reiterates Buy Rating on Boston Scientific (BSX) - Finviz
UBS reiterates buy rating on Boston Scientific (BSX) - MSN
Is Boston Scientific Corporation stock vulnerable to regulatory risksGold Moves & Free Community Supported Trade Ideas - Улправда
Foster Victor Wealth Advisors LLC Has $19.35 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Flputnam Investment Management Co. Buys 236,586 Shares of Boston Scientific Corporation $BSX - MarketBeat
How interest rate cuts could boost Boston Scientific Corporation stock2025 Trading Recap & Free Community Supported Trade Ideas - ulpravda.ru
What technical signals suggest for Boston Scientific Corporation stockJuly 2025 Retail & Weekly Hot Stock Watchlists - Bölüm Sonu Canavarı
Breakout Zone: Is Boston Scientific Corporation stock positioned for digital growth eraJuly 2025 Snapshot & Long-Term Safe Investment Ideas - Улправда
Boston Scientific Corporation $BSX Shares Sold by Jackson Square Capital LLC - MarketBeat
Boston Scientific (NYSE:BSX) Downgraded by Wall Street Zen to "Hold" - MarketBeat
Why Boston Scientific Corporation stock could outperform in 2025Take Profit & Safe Capital Growth Stock Tips - ulpravda.ru
Is Boston Scientific Still Attractive After Strong Multi Year Share Price Gains? - Yahoo Finance
Can Boston Scientific Corporation stock continue upward trendJuly 2025 Opening Moves & Weekly High Return Opportunities - Улправда
Osaic Holdings Inc. Has $15.46 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Can Boston Scientific Corporation stock beat market expectations this quarterWeekly Trade Report & Entry and Exit Point Strategies - Улправда
Is Boston Scientific Corporation stock positioned for digital growth eraTrade Entry Report & Free Fast Entry Momentum Trade Alerts - Улправда
Boston Scientific (BSX) Stock After Hours Dec. 18, 2025: Analyst Targets Shift, Options Point to Key Levels, and What to Watch Before Friday’s Open - ts2.tech
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Decoding Boston Scientific's Options Activity: What's the Big Picture?Boston Scientific (NYSE:BSX) - Benzinga
August 2026 Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific Corp (BSX)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
Truist Financial Lowers Boston Scientific (NYSE:BSX) Price Target to $120.00 - MarketBeat
Boston Scientific's Global Expansion: What's Behind the Growth? - Yahoo Finance
Will Boston Scientific Corporation stock outperform tech sector in 2025Earnings Overview Report & Stepwise Swing Trade Plans - Улправда
Channel Wealth LLC Acquires 11,847 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open - ts2.tech
Boston Scientific (NYSE:BSX) Stock Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Boston Scientific (BSX): Revisiting Valuation After Recent Pullback and Ongoing Growth Momentum - simplywall.st
Boston Scientific (BSX) Advances While Market Declines: Some Information for Investors - Yahoo Finance
BSX: Canaccord Genuity Lowers Boston Scientific's Price Target | BSX Stock News - GuruFocus
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Finviz
Boston Scientific (NYSE:BSX) Shares Rise After Strong Device Demand - Kalkine Media
UBS reiterates Buy rating on Boston Scientific stock with $140 price target - Investing.com
Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider - GlobeNewswire Inc.
Boston Scientific Corporation $BSX Position Trimmed by Thurston Springer Miller Herd & Titak Inc. - MarketBeat
Boston Scientific (NYSE:BSX) Price Target Raised to $130.00 - MarketBeat
Oak Thistle LLC Takes Position in Boston Scientific Corporation $BSX - MarketBeat
The Return Trends At Boston Scientific (NYSE:BSX) Look Promising - Yahoo Finance
Gradient Investments LLC Has $22.49 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
Boston Scientific (BSX) Stock News on Dec. 16, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching - ts2.tech
Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance
Grove Bank & Trust Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
B. Riley Wealth Advisors Inc. Takes Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific moves part of Israeli operation to Ireland - Business Post
Gastrointestinal Diagnostics (GI) Market to Reach $5.8 Billion by 2030 - GlobeNewswire Inc.
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
자본화:
|
볼륨(24시간):